Literature DB >> 19296471

Bile acids: trying to understand their chemistry and biology with the hope of helping patients.

Alan F Hofmann1.   

Abstract

An informal review of the author's five decades of research on the chemistry and biology of bile acids in health and disease is presented. The review begins with a discussion of bile acid structure and its remarkable diversity in vertebrates. Methods for tagging bile acids with tritium for metabolic or transport studies are summarized. Bile acids solubilize polar lipids in mixed micelles; progress in elucidating the structure of the mixed micelle is discussed. Extensive studies on bile acid metabolism in humans have permitted the development of physiological pharmacokinetic models that can be used to simulate bile acid metabolism. Consequences of defective bile acid biosynthesis and transport have been clarified, and therapy has been developed. Methods for measuring bile acids have been improved. The rise and fall of medical and contact dissolution of cholesterol gallstones is chronicled. Finally, principles of therapy with bile acid agonists and antagonists are given. Advances in understanding bile acid biology and chemistry have helped to improve the lives of patients with hepatobiliary or digestive disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296471     DOI: 10.1002/hep.22789

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.

Authors:  R R Henry; V R Aroda; S Mudaliar; W T Garvey; H S Chou; M R Jones
Journal:  Diabetes Obes Metab       Date:  2011-11-21       Impact factor: 6.577

2.  Homologue gene of bile acid transporters ntcp, asbt, and ost-alpha in rainbow trout Oncorhynchus mykiss: tissue expression, effect of fasting, and response to bile acid administration.

Authors:  Koji Murashita; Yasutoshi Yoshiura; Shin-Ichi Chisada; Hirofumi Furuita; Tsuyoshi Sugita; Hiroyuki Matsunari; Yasuro Iwashita; Takeshi Yamamoto
Journal:  Fish Physiol Biochem       Date:  2013-09-12       Impact factor: 2.794

Review 3.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

4.  Managing bile acid diarrhoea.

Authors:  Julian R F Walters; Sanjeev S Pattni
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 5.  Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.

Authors:  Mai Sedki; Cynthia Levy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

6.  Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy.

Authors:  Valgardur Sigurdsson; Youichi Haga; Hajime Takei; Els Mansell; Chizuko Okamatsu-Haga; Mitsuyoshi Suzuki; Visnja Radulovic; Mark van der Garde; Shuhei Koide; Svetlana Soboleva; Mats Gåfvels; Hiroshi Nittono; Akira Ohara; Kenichi Miharada
Journal:  Blood Adv       Date:  2020-05-12

7.  Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.

Authors:  Youcai Zhang; Andrew J Lickteig; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-22       Impact factor: 4.219

Review 8.  BCL2L13: physiological and pathological meanings.

Authors:  Fei Meng; Naitong Sun; Dongyan Liu; Jia Jia; Jun Xiao; Haiming Dai
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

Review 9.  Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.

Authors:  Ann C Muls; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2012-10-02

10.  Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.

Authors:  Youcai Zhang; Andrew J Lickteig; Jing Liu; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-29       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.